Search

Search Results

• 

  Intraparenchymal cerebral hemorrhage in a patient undergoing treatment with galcanezumab: the importance of adequate blood pressure control

  Yan Tereshko, Antonio Taglialatela, Iacopo Cancelli, Enrico Belgrado, Lorenzo Verriello, Giovanni Merlino, Mariarosaria Valente

  05-09-2025

  https://doi.org/10.4081/cc.2025.15786

  676

  PDF: 197

• PO-78 | No changes in blood pressure assessed with the 24-hour Holter monitoring in patients treated with anti-CGRP monoclonal antibodies: a prospective observational study (SAFHYPER) Flavia Lo Castro,¹ Niccolò Bonini,² Luigi Francesco Iannone,^1,3 Alberto Boccalini,¹ Daria Brovia,¹ Luca Pani,^1,3 Giuseppe Boriani,^2,3 Simona Guerzoni¹ | ¹Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse-Laboratory of Clinical Pharmacology and Pharmacogenomics, AOU Policlinico di Modena, Modena, Italy; ²Cardiology Division, AOU Policlinico di Modena, Modena, Italy; ³Department of Biomedical, Metabolic, and Neural Science, University of Modena and Reggio Emilia, Modena, Italy

  Società Italiana per lo Studio delle Cefalee (SISC)

  06-11-2025

  https://doi.org/10.4081/cc.2025.15902

  299